telmisartan has been researched along with Liver Cirrhosis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fathy, M; Fawzy, MA; Khalifa, EMMA | 1 |
| Choi, CS; Han, YI; Kang, KW; Mok, JS; Park, HD; Park, J; Park, JG; Park, TS | 1 |
| Ackley, JC; Andersen, JN; Baddour, J; Blume-Jensen, P; Brady, SW; Chickering, DE; Economides, KD; Ehrlich, DC; Golder, MR; Held, EJ; Huh, SJ; Johnson, JA; Kopesky, PW; Liu, J; Neenan, AM; Nguyen, HV; Paramasivan, S; Reiter, LA; Saucier-Sawyer, JK; Shipitsin, MV; Vangamudi, B; Vohidov, F | 1 |
| Attia, YM; El-Khatib, AS; Elalkamy, EF; Hammam, OA; Mahmoud, SS | 1 |
| Breitbart, E; Ishai, E; Mendel, I; Shoham, A; Yacov, N | 1 |
| Bojarska, A; Brzozowski, T; Celinski, K; Czechowska, G; Dudka, J; Korolczuk, A; Madro, A; Wojcicka, G | 1 |
| Badea, O; Bejenaru, C; Bejenaru, LE; ChiriŢă, C; Ionică, FE; Mogoantă, L; Negreş, S; Nicola, GC; Popescu, NL; Turculeanu, A | 1 |
| Kanayama, M; Kawai, K; Kudo, H; Mann, DA; Morita, S; Nakayama, Y; Oya, T; Sasahara, M; Sugiyama, T; Takahara, T; Yata, Y | 1 |
| Aso, K; Haneda, M; Kanamori, H; Makino, Y; Nakade, Y; Nakao, H; Ohashi, T; Okada, M; Sato, K; Tamaki, Y; Yamauchi, T; Yokohama, S; Yoneda, M | 1 |
| Liu, RX; Wen, Y; Yi, ET; Yin, CH | 1 |
| Jin, H; Sakaida, I; Terai, S; Uchida, K; Yamamoto, N | 1 |
11 other study(ies) available for telmisartan and Liver Cirrhosis
| Article | Year |
|---|---|
Modulation of inducible nitric oxide synthase pathway by eugenol and telmisartan in carbon tetrachloride-induced liver injury in rats.
Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Drug Therapy, Combination; Eugenol; Glutathione; Interleukin-6; Liver Cirrhosis; Male; Malondialdehyde; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Telmisartan; Tumor Necrosis Factor-alpha | 2019 |
Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan.
Topics: Angiotensins; Animals; Cell Line, Tumor; Inflammation; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Telmisartan; Transcriptome | 2019 |
Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Carbon Tetrachloride; Disease Models, Animal; Drug Design; Female; Gene Expression Regulation; Half-Life; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Polymers; Prodrugs; Rats; Rats, Sprague-Dawley; Telmisartan | 2018 |
Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anthelmintics; Benzimidazoles; Benzoates; Disease Models, Animal; Drug Therapy, Combination; Liver; Liver Cirrhosis; Male; Mice; PPAR gamma; Praziquantel; Schistosomiasis mansoni; Telmisartan; Treatment Outcome | 2013 |
Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Blotting, Western; Cell Movement; Cytokines; Dendritic Cells; Diabetes Mellitus, Experimental; Diet, High-Fat; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glycerophosphates; Glycerylphosphorylcholine; Hepatic Stellate Cells; Humans; Inflammation; Kupffer Cells; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Monocytes; Non-alcoholic Fatty Liver Disease; Phospholipids; Pyridinium Compounds; Real-Time Polymerase Chain Reaction; Telmisartan; Toll-Like Receptor 2; Toll-Like Receptor 4; Triglycerides | 2016 |
The effect of the angiotensin II receptor, type 1 receptor antagonists, losartan and telmisartan, on thioacetamide-induced liver fibrosis in rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antioxidants; Aryldialkylphosphatase; Aspartate Aminotransferases; Benzimidazoles; Benzoates; Cytokines; Glutathione; Glutathione Disulfide; Liver; Liver Cirrhosis; Losartan; Male; Rats, Wistar; Telmisartan; Thioacetamide | 2016 |
Antifibrotic action of telmisartan in experimental carbon tetrachloride-induced liver fibrosis in Wistar rats.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbon Tetrachloride; Female; Liver Cirrhosis; Rats; Rats, Wistar; Telmisartan | 2016 |
Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue.
Topics: Adipocytes; Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Cell Line; Cell Size; Chemokine CCL2; Choline Deficiency; Collagen Type I; Disease Models, Animal; Disease Progression; Drinking; Eating; Fatty Liver; Intra-Abdominal Fat; Liver; Liver Cirrhosis; Macrophages; Male; Methionine; Mice; Mice, Inbred C57BL; Organ Size; Oxidative Stress; Receptors, CCR2; RNA, Messenger; Telmisartan; Transforming Growth Factor beta1; Triglycerides | 2009 |
Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.
Topics: Amino Acids; Angiotensin II Type 1 Receptor Blockers; Animals; Anticarcinogenic Agents; Benzimidazoles; Benzoates; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Choline Deficiency; Diet; Drug Evaluation, Preclinical; Fatty Liver; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Liver; Liver Cirrhosis; Liver Neoplasms, Experimental; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Telmisartan; Vascular Endothelial Growth Factor A | 2013 |
Telmisartan attenuates hepatic fibrosis in bile duct-ligated rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Benzimidazoles; Benzoates; Bile Ducts; Blotting, Western; Disease Models, Animal; Immunohistochemistry; Ligation; Liver Cirrhosis; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Telmisartan | 2012 |
Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient L-amino acid-defined diet.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Choline Deficiency; Dose-Response Relationship, Drug; L-Amino Acid Oxidase; Liver Cirrhosis; Male; Rats; Rats, Wistar; Telmisartan; Treatment Outcome | 2007 |